SCHEMBL24317059

SCHEMBL24317059

CNCC(C)C1CCc2cc(F)ccc2C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 1/20 0.49
HTR1B P28222 1/20 0.49
PRMT5 O14744 2/20 0.39
KCNH2 Q12809 4/20 0.38
OPRM1 P35372 3/20 0.38
OPRK1 P41145 3/20 0.38
ADRA2A P08913 2/20 0.38
ADRA2B P18089 2/20 0.38
ADRA2C P18825 2/20 0.38
SLC6A4 P31645 2/20 0.38
HTR2C P28335 2/20 0.38
MLNR O43193 1/20 0.38
ADRB2 P07550 1/20 0.38
ADRB1 P08588 1/20 0.38
HTR1A P08908 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
CHRM1 P11229 1/20 0.38
DRD2 P14416 1/20 0.38
KCNE1 P15382 1/20 0.38
CNR1 P21554 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20006770 0.84 HTR1D (0.52) HTR1DHTR1BPRMT5KCNH2OPRM1
SCHEMBL23940661 0.83 HTR1D (0.48) HTR1DHTR1BPRMT5KCNH2OPRM1
SCHEMBL23940696 0.83 HTR1D (0.48) HTR1DHTR1BPRMT5KCNH2OPRM1
SCHEMBL20006880 0.81 HTR1D (0.45) HTR1DHTR1BPRMT5KCNH2OPRM1
SCHEMBL24316813 0.75 HTR1D (0.39) HTR1DHTR1BPRMT5KCNH2OPRM1
SCHEMBL18900425 0.74 ALDH1A1 (0.35) HTR1DHTR1BOPRK1MCHR1ALDH1A1
SCHEMBL20006885 0.74 HTR1D (0.51) HTR1DHTR1BPRMT5KCNH2OPRM1
SCHEMBL20006982 0.72 HTR1D (0.49) HTR1DHTR1BPRMT5KCNH2OPRM1
SCHEMBL13533180 0.70 SLC6A4 (0.43) HTR1DHTR1BKCNH2OPRM1OPRK1
SCHEMBL7273416 0.69 HTR1D (0.40) HTR1DHTR1BPRMT5KCNH2OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3974419-A2 NEBIVOLOL SYNTHESIS METHOD AND INTERMEDIATE COMPOUND THEREOF Zhejiang Ausun Pharmaceutical Co., Ltd. (CN) 2022-03-30 EP disclosed